Effects of age on the quality of care provided to older patients with acute myocardial infarction

American Journal of Medicine

Volumn 114, Issue 4, 2003, Pages 307-315

  Rathore, Saif S ^a   Mehta, Rajendra H ^b   Wang, Yongfei ^a   Radford, Martha J ^a,c,d   Krumholz, Harlan M ^a,c,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c YALE NEW HAVEN HOSPITAL   (United States)

^d QUALIDIGM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; AGE; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DRUG USE; EVALUATION; FEMALE; GEOGRAPHY; GERIATRIC CARE; HEART MUSCLE REPERFUSION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TREATMENT CONTRAINDICATION;

EID: 0037353405     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(02)01531-0     Document Type: Article

References (34)

1. Udvarhelyi I.S., Gatsonis C., Epstein A.M., et al. Acute myocardial infarction in the Medicare population: process of care and clinical outcomes. JAMA. 268:1992;2530-2536.
2. Gurwitz J.H., Osganian V., Goldberg R.J., et al. Diagnostic testing in acute myocardial infarction: does patient age influence utilization patterns? The Worcester Heart Attack Study. Am J Epidemiol. 134:1991;948-957.
3. Rosenthal G.E., Fortinsky R.H. Differences in the treatment of patients with acute myocardial infarction according to patient age. J Am Geriatr Soc. 42:1994;826-832.
4. Krumholz H.M., Murillo J.E., Chen J., et al. Thrombolytic therapy for eligible elderly patients with acute myocardial infarction. JAMA. 277:1997;1683-1688.
5. Tsuyuki R.T., Teo K.K., Ikuta R.M., et al. Mortality risk and patterns of practice in 2,070 patients with acute myocardial infarction, 1987-1992. Chest. 105:1994;1687-1692.
6. McLaughlin T.J., Soumerai S.B., Willison D.J., et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and elderly. Arch Intern Med. 156:1996;799-805.
7. Chandra H., Yarzebski J., Goldberg R.J., et al. Age-related trends (1986-1993) in the use of thrombolytic agents in patients with acute myocardial infarction: the Worcester Heart Attack Study. Arch Intern Med. 157:1997;741-746.
8. Translation of clinical trials into practice: a European population-based study of the use of thrombolysis for acute myocardial infarction. Lancet. 347:1996;1203-1207.
9. Montague T.J., Ikuta R.M., Wong R.Y., et al. Comparison of risk and patterns of practice in patients older and younger than 70 years with acute myocardial infarction in a two year period (1987-1989). Am J Cardiol. 68:1991;843-847.
10. Pfeffer M.A., Moye L.A., Braunwald E., et al. Selection bias in the use of thrombolytic therapy in acute myocardial infarction. JAMA. 266:1991;528-532.
11. Weaver W.D., Litwin P.E., Martin J.S., et al. Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. J Am Coll Cardiol. 18:1991;657-662.
12. Gurwitz J.H., Gore J.M., Goldberg R.J., et al. Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction. Ann Intern Med. 124:1996;283-291.
13. Rogers W.J., Bowlby L.J., Chandra N.C., et al. Treatment of myocardial infarction in the United States (1990 to 1993): observations from the National Registry of Myocardial Infarction. Circulation. 90:1994;2103-2114.
14. Montague T.J., Wong R.Y., Burton J.R., et al. Changes in acute myocardial infarction risk and patterns of practice for patients older and younger than 70 years, 1987-90. Can J Cardiol. 8:1992;596-600.
15. Montague T., Wong R., Crowell R., et al. Acute myocardial infarction: contemporary risk and management in older versus younger patients. Can J Cardiol. 6:1990;241-246.
16. Barakat K., Wilkinson P., Deaner A., et al. How should age affect management of acute myocardial infarction? Lancet. 353:1999;955-959.
17. Krumholz H.M., Radford M.J., Ellerbeck E.F., et al. Aspirin in the treatment of acute myocardial infarction in elderly Medicare beneficiaries: patterns of use and outcomes. Circulation. 92:1995;2841-2847.
18. Gurwitz J.H., Goldberg R.J., Chen Z., et al. Beta-blocker therapy in acute myocardial infarction: evidence for underutilization in the elderly. Am J Med. 93:1992;605-610.
19. Smith S.C.J., Gilpin E., Ahnve S., et al. Outlook after acute myocardial infarction in the very elderly compared with that in younger patients aged 65 to 75 years. J Am Coll Cardiol. 16:1990;784-792.
20. Jencks S.F., Cuerdon T., Burwen D.R., et al. Quality of medical care delivered to Medicare beneficiaries: a profile at national and state levels. JAMA. 284:2001;1670-1676.
21. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: U.S. Government Printing Office;1997.
22. Marciniak T.A., Ellerbeck E.F., Radford M.J., et al. Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. JAMA. 279:1998;1351-1357.
23. Ryan T.J., Anderson J.K., Antman E.M., et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 28:1996;1328-1428.
24. Zhang J., Yu K.F. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 280:1998;1690-1691.
25. White H.A. A heteroskedasticity-consistent covariance matrix esti-mator and a direct test of heteroskedasticity. Econometrica. 48:1980;817-838.
26. Bayer A.J., Chadha J.S., Farag R.R., Pathy M.S. Changing presentation of myocardial infarction with increasing old age. J Am Geriatr Soc. 34:1986;263-266.
27. Krumholz H.M., Radford M.J., Ellerbeck E.F., et al. Aspirin for secondary prevention after acute myocardial infarction in the elderly: prescribed use and outcomes. Ann Intern Med. 124:1996;292-298.
28. McLaughlin T.J., Soumerai S.B., Willison D.J., et al. The effect of comorbidity on use of thrombolysis or aspirin in patients with acute myocardial infarction eligible for treatment. J Gen Intern Med. 12:1997;1-6.
29. Bowling A. Ageism in cardiology. BMJ. 319:1999;1353-1355.
30. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 343:1994;311-322.
31. Thiemann D.R., Coresh J., Schulman S.P., et al. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation. 101:2000;2239-2246.
32. McLaughlin T.J., Gurwitz J.H., Willison D.J., et al. Delayed thrombolytic treatment of older patients with acute myocardial infarction. J Am Geriatr Soc. 47:1999;1222-1228.
33. Krumholz H.M., Friesinger G.C., Cook E.F., et al. Relationship of age with eligibility for thrombolytic therapy and mortality among patients with suspected acute myocardial infarction. J Am Geriatr Soc. 42:1994;127-131.
34. Chen J., Radford M.J., Wang Y., et al. Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma. J Am Coll Cardiol. 37:2001;1950-1956.